Cite

HARVARD Citation

    Linch, S. et al. (n.d.). Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record